Skip to main content
Top
Published in: The Journal of Obstetrics and Gynecology of India 2/2018

01-04-2018 | Invited Mini Review

Short-Term Use of Injectable Contraception: An Effective Strategy for Safe Motherhood

Author: Suvarna Satish Khadilkar

Published in: The Journal of Obstetrics and Gynecology of India | Issue 2/2018

Login to get access

Excerpt

Use of contraception is a substantial and effective preventive strategy to reduce maternal mortality, especially in developing countries. Numbers of unintended pregnancies and unmet contraceptive need are still high in many developing countries, and hence abortion-related deaths are also very high. Every two hours a woman dies from an unsafe abortion in India! Hence, the problem of unsafe abortions is especially acute. There were 620,472 reported abortions in 2012; experts say the true number of abortions performed in the country could be as high as 7 million, with two-thirds of them taking place outside authorized health facilities [1]. The global perception is also stark; the number of women with an unmet need for family planning has been projected to grow to 962 million by 2015. …
Literature
2.
go back to reference Singh S, Darroch JE, Ashford LS, et al. Adding it up: the costs and benefits of investing in family planning and maternal and newborn health. New York: Guttmacher Institute and United Nations Population Fund; 2009. Singh S, Darroch JE, Ashford LS, et al. Adding it up: the costs and benefits of investing in family planning and maternal and newborn health. New York: Guttmacher Institute and United Nations Population Fund; 2009.
3.
go back to reference Liu L, Becker S, Tsui A, et al. Three methods of estimating births averted nationally by contraception. Popul Stud (Camb). 2008;62:191–210.CrossRef Liu L, Becker S, Tsui A, et al. Three methods of estimating births averted nationally by contraception. Popul Stud (Camb). 2008;62:191–210.CrossRef
4.
go back to reference Joshi R, Khadilkar S, Patel M. Global trends in use of long-acting reversible and permanent methods of contraception: seeking a balance. Int J Gynaecol Obstet. 2015;131(Suppl 1):S60–3.CrossRefPubMed Joshi R, Khadilkar S, Patel M. Global trends in use of long-acting reversible and permanent methods of contraception: seeking a balance. Int J Gynaecol Obstet. 2015;131(Suppl 1):S60–3.CrossRefPubMed
5.
go back to reference Said S, Omar K, Koetsawang S, et al. A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1987;35:591–610.CrossRefPubMed Said S, Omar K, Koetsawang S, et al. A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1987;35:591–610.CrossRefPubMed
6.
go back to reference National Collaborating Centre for Women’s and Children’s Health (UK). NICE clinical guidelines, No. 30. London: RCOG Press; 2005. National Collaborating Centre for Women’s and Children’s Health (UK). NICE clinical guidelines, No. 30. London: RCOG Press; 2005.
7.
go back to reference Jain J, Dutton C, Nicosia A, et al. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera(R). Contraception. 2004;70:11–8.CrossRefPubMed Jain J, Dutton C, Nicosia A, et al. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera(R). Contraception. 2004;70:11–8.CrossRefPubMed
8.
go back to reference Task force on long-acting agents for the regulation of fertility. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisteroneenanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report. Contraception. 1983;28:1–20. Task force on long-acting agents for the regulation of fertility. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisteroneenanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report. Contraception. 1983;28:1–20.
9.
go back to reference Sekadde-Kigondu C, Mwathe EG, Ruminjo JK, et al. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya. East Afr Med J. 1996;73:786–94.PubMed Sekadde-Kigondu C, Mwathe EG, Ruminjo JK, et al. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya. East Afr Med J. 1996;73:786–94.PubMed
10.
go back to reference Khadilkar S, Sood A, Shivkar KS, et al. Short term use of INJ DMPA: key to successful family planning programme. Contraception and fertility control (EP9.033). BJOG Int J Obstet Gynaecol. 2016;123:170–7. doi:10.1111/1471-0528.14107.CrossRef Khadilkar S, Sood A, Shivkar KS, et al. Short term use of INJ DMPA: key to successful family planning programme. Contraception and fertility control (EP9.033). BJOG Int J Obstet Gynaecol. 2016;123:170–7. doi:10.​1111/​1471-0528.​14107.CrossRef
11.
go back to reference Schwallie PC, Assenzo JR. The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review. Contraception. 1974;10:181–202.CrossRefPubMed Schwallie PC, Assenzo JR. The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review. Contraception. 1974;10:181–202.CrossRefPubMed
14.
go back to reference Mohllajee AP, Curtis KM. Progestogen-only contraceptive use in obese women. World Health Organization, division of reproductive health, centers for disease control and prevention. US Agency for International Development and National Institute of Child Health and Human Development; 2004. Mohllajee AP, Curtis KM. Progestogen-only contraceptive use in obese women. World Health Organization, division of reproductive health, centers for disease control and prevention. US Agency for International Development and National Institute of Child Health and Human Development; 2004.
Metadata
Title
Short-Term Use of Injectable Contraception: An Effective Strategy for Safe Motherhood
Author
Suvarna Satish Khadilkar
Publication date
01-04-2018
Publisher
Springer India
Published in
The Journal of Obstetrics and Gynecology of India / Issue 2/2018
Print ISSN: 0971-9202
Electronic ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-017-1029-9

Other articles of this Issue 2/2018

The Journal of Obstetrics and Gynecology of India 2/2018 Go to the issue